Breakwater Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2K Sell
79
-15
-16% -$3.33K 0.01% 203
2025
Q4
$21.5K Hold
94
0.01% 189
2025
Q3
$21.8K Buy
94
+29
+45% +$5.91K 0.01% 192
2025
Q2
$12.1K Hold
65
﹤0.01% 216
2025
Q1
$13.6K Hold
65
0.01% 209
2024
Q4
$11.6K Hold
65
﹤0.01% 212
2024
Q3
$12.8K Sell
65
-66
-50% -$12.3K 0.01% 212
2024
Q2
$22.5K Buy
131
+66
+102% +$10.9K 0.01% 182
2024
Q1
$11.8K Buy
+65
New +$11.2K 0.01% 207

Other funds holding ABBV

Breakwater Investment Management's ABBV Position: Q1 2026 in Review

Breakwater Investment Management reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $3.33K and leaving 79 shares worth $17.2K. The position accounts for 0.01% of the portfolio, ranked #203.

Breakwater Investment Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.5K in Q2 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Breakwater Investment Management held 79 shares of AbbVie worth $17.2K as of Q1 2026.
  • Breakwater Investment Management sold 15 AbbVie shares in Q1 2026, an estimated $3.33K.
  • AbbVie made up 0.01% of Breakwater Investment Management's portfolio in Q1 2026, its #203 holding.
  • Breakwater Investment Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • Breakwater Investment Management's AbbVie position peaked at $22.5K in Q2 2024.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Breakwater Investment Management's 13F filing for Q1 2026, filed 15 May 2026.